| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |